Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Changzhou Tronly New Electronic Materials Co., Ltd. (300429.SZ)
Changzhou, CN
Changzhou Tronly New Electronic Materials Co., Ltd., established in 1987 with headquarters in Changzhou, China, operates internationally as a specialist in the research, development, manufacturing, and global distribution of advanced electronic materials and plastic goods. The company's extensive product line features various photoinitiators. The HABI series is predominantly employed in dry film and liquid photoresist systems for printed circuit board (PCB) fabrication, in addition to other photocurable formulations. PBG series photoinitiators are integral to display panel technologies (including RGB and BM photoresists), semiconductor packaging, colored UV-curable inks, coatings, and adhesives. Tronly also provides free radical photoinitiators for a broad spectrum of photocurable coatings, inks, and adhesives, such as those used in wood and plastic finishes, offset printing, and inkjet applications. Correspondingly, cationic photoinitiators address the needs of photocurable coatings, inks, and adhesives, with applications ranging from metal coatings to food packaging printing inks. A distinctive product is KS001, a photoinitiator recognized for its non-reproductive toxicity, low odor, and non-sublimating properties, making it well-suited for solder mask inks, food packaging printing inks, and UV-LED curing systems. Furthermore, the company produces acrylic-based PCB photoresist resins and monomers, vital for both dry film and liquid photoresist systems in PCB manufacturing, as well as for photocurable coatings, inks, and adhesives more broadly. Its fluorene monomer series functions as a base material for black photoresist resins, transparency and refractive resins, heat-resistant resin additives, and reactive diluents within light-curing systems. Completing its offerings, the company supplies photosensitizers, photoacid generators, and associated monomers.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.74% | -10.45% | -2.20% | -14.07% | +1.69% | +3.53% | +12.75% | +37.18% | +14.81% | -28.51% | +255.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+6.6% ★ Q1'26: +15.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+31.4% ★ Q1'26: -406.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-23.9% Q1'26: -3.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-2.2% Q1'26: -6.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-0.8% Q1'26: -2.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-22.1% ★ Q1'26: -22.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×8.11× Q1'26: -18.20× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
334.44M
est: 356.00M (-6.1%)
|
439.58M
est: 467.91M (-6.1%)
|
639.95M
est: 587.00M (+9.0%)
|
739.08M
est: 765.00M (-3.4%)
|
863.91M
est: 926.00M (-6.7%)
|
776.47M
est: 979.13M (-20.7%)
|
1.04B
est: 1.10B (-5.8%)
|
891.05M
est: 1.25B (-28.5%)
|
985.23M
est: 467.91M (+110.6%)
|
587.00M
587.00M – 587.00M
+25.5% YoY
|
765.00M
765.00M – 765.00M
+30.3% YoY
|
926.00M
926.00M – 926.00M
+21.0% YoY
|
979.13M
979.13M – 979.13M
+5.7% YoY
|
1.10B
1.10B – 1.10B
+12.7% YoY
|
1.25B
1.25B – 1.25B
+13.1% YoY
|
| EBITDA |
109.19M
est: 48.91M (+123.2%)
|
142.92M
est: 64.28M (+122.3%)
|
188.21M
est: 80.65M (+133.4%)
|
193.46M
est: 105.10M (+84.1%)
|
209.67M
est: 127.22M (+64.8%)
|
164.01M
est: 134.52M (+21.9%)
|
197.91M
est: 151.54M (+30.6%)
|
89.04M
est: 171.32M (-48.0%)
|
161.13M
est: 59.82M (+169.3%)
|
75.05M
75.05M – 75.05M
+25.5% YoY
|
97.81M
97.81M – 97.81M
+30.3% YoY
|
118.39M
118.39M – 118.39M
+21.0% YoY
|
125.18M
125.18M – 125.18M
+5.7% YoY
|
141.02M
141.02M – 141.02M
+12.7% YoY
|
159.43M
159.43M – 159.43M
+13.1% YoY
|
| EBIT |
92.60M
est: 7.96M (+1,062.6%)
|
116.58M
est: 10.47M (+1,013.7%)
|
150.08M
est: 13.13M (+1,042.8%)
|
146.37M
est: 17.11M (+755.2%)
|
157.33M
est: 20.72M (+659.5%)
|
104.73M
est: 21.90M (+378.1%)
|
127.91M
est: 24.68M (+418.4%)
|
-15.09M
est: 27.90M (-154.1%)
|
-21.94M
est: -4.24M (-417.7%)
|
-5.32M
-5.32M – -5.32M
-25.5% YoY
|
-6.93M
-6.93M – -6.93M
-30.3% YoY
|
-8.39M
-8.39M – -8.39M
-21.0% YoY
|
-8.87M
-8.87M – -8.87M
-5.7% YoY
|
-9.99M
-9.99M – -9.99M
-12.7% YoY
|
-11.29M
-11.29M – -11.29M
-13.1% YoY
|
| Net Income |
86.51M
est: 134.33M (-35.6%)
|
116.02M
est: 167.77M (-30.8%)
|
126.59M
est: 188.28M (-32.8%)
|
146.56M
est: 206.39M (-29.0%)
|
150.61M
est: 254.55M (-40.8%)
|
92.87M
est: 261.43M (-64.5%)
|
114.85M
est: 316.47M (-63.7%)
|
-92.66M
est: 371.50M (-124.9%)
|
-127.35M
est: 130.76M (-197.4%)
|
146.75M
146.75M – 146.75M
+12.2% YoY
|
160.86M
160.86M – 160.86M
+9.6% YoY
|
198.40M
198.40M – 198.40M
+23.3% YoY
|
203.76M
203.76M – 203.76M
+2.7% YoY
|
246.66M
246.66M – 246.66M
+21.1% YoY
|
289.55M
289.55M – 289.55M
+17.4% YoY
|
| SGA |
51.91M
est: 48.90M (+6.1%)
|
67.55M
est: 64.28M (+5.1%)
|
67.78M
est: 80.64M (-15.9%)
|
90.99M
est: 105.09M (-13.4%)
|
111.55M
est: 127.21M (-12.3%)
|
105.87M
est: 134.50M (-21.3%)
|
106.05M
est: 151.52M (-30.0%)
|
142.08M
est: 171.30M (-17.1%)
|
93.62M
est: 60.41M (+55.0%)
|
75.79M
75.79M – 75.79M
+25.5% YoY
|
98.77M
98.77M – 98.77M
+30.3% YoY
|
119.55M
119.55M – 119.55M
+21.0% YoY
|
126.41M
126.41M – 126.41M
+5.7% YoY
|
142.40M
142.40M – 142.40M
+12.7% YoY
|
160.99M
160.99M – 160.99M
+13.1% YoY
|
| EPS |
0.20
est: 0.20 (+2.4%)
|
0.24
est: 0.24 (-0.4%)
|
0.26
est: 0.27 (-5.0%)
|
0.29
est: 0.30 (-3.3%)
|
0.29
est: 0.37 (-21.0%)
|
0.18
est: 0.38 (-52.6%)
|
0.22
est: 0.46 (-51.5%)
|
-0.18
est: 0.54 (-133.3%)
|
-0.24
est: 0.24 (-198.4%)
|
0.27
0.27 – 0.27
+12.2% YoY
|
0.30
0.30 – 0.30
+9.6% YoY
|
0.37
0.37 – 0.37
+23.3% YoY
|
0.38
0.38 – 0.38
+2.7% YoY
|
0.46
0.46 – 0.46
+21.1% YoY
|
0.54
0.54 – 0.54
+17.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 342.1K | 0.06% |
| 2 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 8.6K | 0.48% |
| 3 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 19.4K | 0.26% |
| 4 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 958.0K | 0.06% |
| 5 | Vanguard ESG International Stock ETF VSGX | 0.00% | 15.7K | 0.10% |
| 6 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.25M | 0.05% |
| 7 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 1.5K | 0.22% |
| 8 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 4.6K | 0.22% |
| 9 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 2.5K | 0.22% |
| 10 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 1.1K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bing Wang | Vice President | — | male |
| Jian Xin Yang | Vice President | — | male |
| Jingjing Pan | Vice President & Financial Director | — | female |
| Xiaochun Qian | Chairman & President | — | male |
| Xue Long Zhang | Vice President | — | male |
| Yinsen Ni | Vice President, Board Secretary & Director | — | male |
| Zhicheng Meng | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300429.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
